# Impact of Glucagon-like Peptide-1 (GLP-1) Analogs on Disease Outcomes in Psoriatic Arthritis: A Pragmatic Randomized Controlled Trial

> **NCT07111494** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Medical College of Wisconsin** · enrollment: 22 (estimated)

## Conditions studied

- Psoriatic Arthritis (PsA)

## Interventions

- **DRUG:** GLP-1 agonists
- **OTHER:** Nutrition Counseling

## Key facts

- **NCT ID:** NCT07111494
- **Lead sponsor:** Medical College of Wisconsin
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-10-15
- **Primary completion:** 2026-10-15
- **Final completion:** 2028-10-15
- **Target enrollment:** 22 (ESTIMATED)
- **Last updated:** 2025-08-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07111494

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07111494, "Impact of Glucagon-like Peptide-1 (GLP-1) Analogs on Disease Outcomes in Psoriatic Arthritis: A Pragmatic Randomized Controlled Trial". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT07111494. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*